C
Christopher S. King
Researcher at Inova Fairfax Hospital
Publications - 82
Citations - 1431
Christopher S. King is an academic researcher from Inova Fairfax Hospital. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Interstitial lung disease. The author has an hindex of 13, co-authored 82 publications receiving 559 citations.
Papers
More filters
Journal ArticleDOI
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.
Scott M. Stevens,Scott C. Woller,Lisa Baumann Kreuziger,Henri Bounameaux,Kevin C. Doerschug,Geert-Jan Geersing,Menno V. Huisman,C. Kearon,Christopher S. King,Andrew J. Knighton,Erica Lake,Susan Murin,Janine R.E. Vintch,Philip S. Wells,Lisa K. Moores +14 more
TL;DR: The 2nd update to the 9th edition of these guidelines is presented in this article, where the authors provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.
Journal ArticleDOI
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M. Stevens,Scott C. Woller,Lisa Baumann Kreuziger,Henri Bounameaux,Kevin C. Doerschug,Geert-Jan Geersing,Menno V. Huisman,Clive Kearon,Christopher S. King,Andrew J. Knighton,Erica Lake,Susan Murin,Janine R.E. Vintch,Philip S. Wells,Lisa K. Moores +14 more
TL;DR: The 2nd update to the 9th edition of these guidelines is presented in this article, where the authors provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.
Journal ArticleDOI
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
TL;DR: Optimal management of IPF requires a comprehensive approach, which includes the identification and treatment of comorbid conditions to optimise patient outcomes.
Journal ArticleDOI
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
Abhimanyu Chandel,Saloni Patolia,A. Whitney Brown,A. Claire Collins,Dhwani Sahjwani,Vikramjit Khangoora,Paula C Cameron,Mehul Desai,Aditya Kasarabada,Jack K Kilcullen,Steven D. Nathan,Christopher S. King +11 more
TL;DR: In this retrospective review, HFNC was a viable strategy and mechanical ventilation was avoided in the majority of subjects and the ROX index was sensitive for the identification of subjects successfully weaned from HFNC.
Journal ArticleDOI
Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure.
Christopher S. King,Dhwani Sahjwani,A. Whitney Brown,Saad Feroz,Paula C Cameron,Erik Osborn,Mehul Desai,Svetolik Djurkovic,Aditya Kasarabada,Rachel Hinerman,James Lantry,Oksana A. Shlobin,Kareem Ahmad,Vikramjit Khangoora,Shambhu Aryal,A. Claire Collins,Alan M. Speir,Steven D. Nathan +17 more
TL;DR: Mortality of patients with COVID-19 requiring invasive mechanical ventilation is high, with particularly daunting mortality seen in patients of advanced age, even in a well-resourced health care system, according to an electronic medical record review.